Find clinical trials for Heart Disease in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Atlanta, GA, USA:
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Atlanta, Georgia, United States and 2 other locations
This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the...
Marietta, Georgia, United States of America and 16 other locations
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...
Atlanta, Georgia, United States and 61 other locations
The VITALYST Early Feasibility study (EFS) is designed to evaluate the feasibility and safety of the VITALYST System in subjects undergoing elective...
Atlanta, Georgia, United States and 4 other locations
The goal of this Phase I Open-Label study is to demonstrate the safety and feasibility of VentriGel injection in children with Hypoplastic Left Heart...
Phase 1
Atlanta, Georgia, United States
have suggested that the addition of hormone therapy may worsen heart (cardiac) disease and high blood pressure. In fact, s...
Phase 3
Atlanta, Georgia, United States and 3 other locations
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve....
Atlanta, Georgia, United States and 11 other locations
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...
Atlanta, Georgia, United States and 13 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Atlanta, Georgia, United States and 6 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Atlanta, Georgia, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal